期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

增生型糖尿病视网膜病变患者玻璃体腔注射avastin后房水中VEGF和PEDF的变化 被引量：5

下载PDF
导出
作者 许菲 邢怡桥 陈长征 韩国鸽 刘增平
机构地区 武汉大学人民医院眼科
出处 《眼科研究》 CSCD 北大核心 2010年第3期219-220,共2页 Chinese Ophthalmic Research
基金 湖北省重大项目重大眼部疾病预防与临床技术研究 湖北省科技项目眼科疾病防治技术研究(2006AA301B58)资助
关键词 增生型糖尿病视网膜病变 糖尿病视网膜病变患者 AVASTIN 玻璃体腔注射 PEDF VEGF bevacizumab 后房水
分类号 R774.1 [医药卫生—眼科] R979.1 [医药卫生—药品]
  • 相关文献

参考文献8

  • 1Ogata N, Nishikawa M, Nishimura T,et al. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy [ J ]. Am J Ophthalmo1,2002,134 ( 3 ) : 348 - 353.
  • 2Minnella AM, Savastano CM, Ziceardi L, et al. Intravitreal bevacizumab ( Avastin ( R ) ) in proliferative diabetic retinopathy [ J ]. Acta Ophthahnologica, 2008,86 : 683-687.
  • 3刘家琦,李凤鸣.实用眼科学[M].北京:人民卫生出版社,2006:882.
  • 4Duh EJ, Yang HS, Suzuma I, et al. Pigment epithelium-derived factor suppressed ischemia-included retina neovascularization and VEGF- included migration and growth[ J]. Invest Ophthalmol Vis Sci ,2002,43: 821 - 829.
  • 5Funatsu H. Yamashita H, Noma H, et al. Aqueous humor levels of cytokines are related tovitreous levels and progression of diabetic retinopathy in diabetic patients[ J ]. Graefe' s Arch Clin Exp Ophthalmol, 2005.243(1 ):3 - 8.
  • 6Sawada O, Kawamura H, Kakinoki M, et al. Vascular endothlial growth factor in aqueous humor befnre and after intravitreal injection of bevacizumab in eyes with diabetic' retinopathy [ J ]. Arch Ophthamology, 2007,125:1363 - 1366.
  • 7Wai MC. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovaseularization secondary to age-related macular degeneratioon or pathologic myopia [ J ]. Retina, 2008, 28 : 1308 - 1313.
  • 8Tong JP, Yao YF. Contribution of VEGF and PEDF to choroidal angiogenesis : a need for balanced expressions [ J ]. Clin Biochem, 2006, 39:267 - 276.

共引文献14

同被引文献51

  • 1齐慧君,黎晓新.糖尿病性黄斑水肿的激光治疗[J].眼科,2005,14(4):234-236. 被引量：35
  • 2Senger DR,Van De Water L,Brown LF,et a1.Vascular permcability factor(VPF,VEGF)in tumor biology[J].Cancer Metasta Rev,1993,12(3/4):303-324.
  • 3Witmer AN,Vrensen GF,Van Noorden CJ,et al.Vascular endothelial growth factors and angiogenesis in eye disease[J].Prog Retin Eye Res,2003,22(1):1-29.
  • 4Symes RJ,Poole TR.Cor neal graft surger y combined with subconjunctival bevacizumab(avastin)[J].Cornea,2010,29(6):691-693.
  • 5Lin CT,Hu FR,Kuo KT,et al.The different effects of early and late bevacizumab(Avastin)injection on inhibiting corneal neovascularization and conjunctivalization in rabbit limbal insufficiency[J].Invest Ophthalmol Vis Sci,2010,51(12):6277-6285.
  • 6Ogata N,Nishikawa M,Nishimura T,et al.Unbanlanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy[J].Am J Ophthalmol,2002,134(3):348-353.
  • 7Schmidinger G,Maar N,Bolz M,et al.Repeated intravitreal bevacizumab(Avastin(R))treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation[J].Acta Ophthal mol,2011,89(1):76-81.
  • 8乔翠芳.玻璃腔注射Avastin治疗脉络膜新生血管性疾病[J].中外健康文摘,2012,9(45):190-191.
  • 9Macky TA,Mahgoub MM.Electrophysiological assessment of optic nerve and retinal functions following intravitreal injection of bevacizumab(avastin)[J].J Ocul Pharmacol Ther,2012,28(2):159-165.
  • 10Freeman WR,Kozak I,Yuson RM,et al.Prognosti implications of pigment epithelial detachment in bevacizumab(avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization[J].Retina,2011,31(9):1812-1818.

引证文献5

二级引证文献54

眼科研究
2010年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部